Halozyme Therapeutics HALO
NASDAQ HALO
$108.34 +1.40 (+1.31%)
As of: Oct 2, 2026 · 11:07 AM EDT

Halozyme Therapeutics (HALO) Shares Outstanding (Entity) (2010 - 2026)

Updated

Halozyme Therapeutics (HALO) reported Shares Outstanding (Entity) of 114.04 million for Q2 2026, down 3.0% from 117.62 million a year earlier and down 3.8% from the prior quarter.

Analysis

Halozyme Therapeutics (HALO) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends

For FY2025, Halozyme Therapeutics posted Shares Outstanding (Entity) of 117.78 million, down 4.3% from FY2024.

  • Shares Outstanding (Entity) has declined for four consecutive years, with a five-year compound annual growth rate of -2.9% (FY2020 to FY2025).
  • By year, Shares Outstanding (Entity) came in at 123.14 million in FY2024 (-2.9%), 126.77 million in FY2023 (-6.2%), 135.15 million in FY2022 (-2.0%) and 137.89 million in FY2021 (+0.9%).
  • The Q2 2026 figure ranks as the lowest quarterly Shares Outstanding (Entity) since Q3 2013.
  • Year over year, Shares Outstanding (Entity) has now declined in each of the last 18 quarters, with an average decline of 4.4% over the last eight quarters.
  • The high point for year-over-year Shares Outstanding (Entity) in five years was Q3 2021 (growth of 4.1%); the low point was Q3 2025 (a decline of 7.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 118.52 million (Q1 2026), 117.78 million (Q4 2025) and 117.52 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Halozyme Therapeutics 12.59 Bn 11.20 Bn 401.83 Mn 114.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 114.04 Mn
Mar 31, 2026 118.52 Mn
Dec 31, 2025 117.78 Mn
Sep 30, 2025 117.52 Mn
Jun 30, 2025 117.62 Mn
Mar 31, 2025 123.17 Mn
Dec 31, 2024 123.14 Mn
Sep 30, 2024 127.18 Mn
Jun 30, 2024 126.54 Mn
Mar 31, 2024 127.19 Mn
Dec 31, 2023 126.77 Mn
Sep 30, 2023 132.08 Mn
Jun 30, 2023 131.86 Mn
Mar 31, 2023 131.66 Mn
Dec 31, 2022 135.15 Mn
Sep 30, 2022 135.21 Mn
Jun 30, 2022 137.68 Mn
Mar 31, 2022 137.89 Mn
Dec 31, 2021 137.89 Mn
Sep 30, 2021 140.97 Mn
API Access

Halozyme Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=HALO&period=max&api_key=YOUR_API_KEY